[1]

Danpanichkul P, Suparan K, Tothanarungroj P, Dejvajara D, Rakwong K, et al. 2024. Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021. Gut 74:26−34

doi: 10.1136/gutjnl-2024-333227
[2]

Cao W, Chen HD, Yu YW, Li N, Chen WQ. 2021. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chinese Medical Journal 134:783−791

doi: 10.1097/CM9.0000000000001474
[3]

Xia C, Dong X, Li H, Cao M, Sun D, et al. 2022. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chinese Medical Journal 135:584−590

doi: 10.1097/CM9.0000000000002108
[4]

Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, et al. 2017. ESPEN guidelines on definitions and terminology of clinical nutrition. Clinical Nutrition 36:49−64

doi: 10.1016/j.clnu.2016.09.004
[5]

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. 2017. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition 36:11−48

doi: 10.1016/j.clnu.2016.07.015
[6]

Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, et al. 2020. Effects of nutritional interventions on nutritional status in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 38:28−42

doi: 10.1016/j.clnesp.2020.05.007
[7]

Zou Q, Yin Z, Ding L, Ruan J, Zhao G, et al. 2024. Effect of preoperative oral nutritional supplements on clinical outcomes in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. Medicine 103:e39844

doi: 10.1097/MD.0000000000039844
[8]

Chinese Society for Parenteral and Enteral Nutrition (CSPEN), Yang H, Zhu MW, Chen W, Wang XY. 2023. Guideline for clinical application of parenteral and enteral nutrition in adults patients in China. Chinese Medical Journal 103:946−974

doi: 10.3760/cma.j.cn112137-20221116-02407
[9]

Key Laboratory of Cancer FSMP for State Market Regulation, Formula Food for Special Medical Purposes Application Committee, China Nutrition and Health Food Association, Chinese Society of Nutritional Oncology. 2022. Guidelines for the use of formula food for special medical purposes in cancer patients. Electronic Journal of Metabolism and Nutrition of Cancer 9:572−579
[10]

Chinese Society for Parenteral and Enteral Nutrition. 2017. 肿瘤患者营养支持指南 [Guidelines on nutritional support in patients with tumor]. 中华外科杂志 [Chinese Journal of Surgery] 55:801−829 (in Chinese)
[11]

August DA, Huhmann MB. 2009. A. S. P. E. N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. Journal of Parenteral and Enteral Nutrition 33:472−500

doi: 10.1177/0148607109341804
[12]

Tan S, Meng Q, Jiang Y, Zhuang Q, Xi Q, et al. 2021. Impact of oral nutritional supplements in post-discharge patients at nutritional risk following colorectal cancer surgery: A randomised clinical trial. Clinical Nutrition 40:47−53

doi: 10.1016/j.clnu.2020.05.038
[13]

Bally MR, Blaser Yildirim PZ, Bounoure L, Gloy VL, Mueller B, et al. 2016. Nutritional support and outcomes in malnourished medical inpatients: a systematic review and meta-analysis. JAMA Internal Medicine 176:43−53

doi: 10.1001/jamainternmed.2015.6587
[14]

Adiamah A, Lobo DN. 2021. Post-discharge oral nutritional supplementation after surgery for gastrointestinal cancer: Real or marginal gains? Clinical Nutrition 40:1−3

doi: 10.1016/j.clnu.2020.06.001
[15]

Das M. 2017. Neoadjuvant chemotherapy: survival benefit in gastric cancer. The Lancet Oncology 18:e307

doi: 10.1016/s1470-2045(17)30321-2
[16]

Coutzac C, Pernot S, Chaput N, Zaanan A. 2019. Immunotherapy in advanced gastric cancer, is it the future? Critical Reviews in Oncology/Hematology 133:25−32

doi: 10.1016/j.critrevonc.2018.10.007
[17]

Patel AA. 2024. Recent advances in immunotherapy in cancer treatment. Cellular and Molecular Biology 70:89−99

doi: 10.14715/cmb/2024.70.5.13
[18]

Adiamah A, Skořepa P, Weimann A, Lobo DN. 2019. The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. Annals of Surgery 270:247−256

doi: 10.1097/SLA.0000000000003256
[19]

Arends J. 2024. Malnutrition in cancer patients: Causes, consequences and treatment options. European Journal of Surgical Oncology 50:107074

doi: 10.1016/j.ejso.2023.107074
[20]

Bossi P, Delrio P, Mascheroni A, Zanetti M. 2021. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients 13(6):1980

doi: 10.3390/nu13061980
[21]

Argilés JM, López-Soriano FJ, Busquets S. 2013. Mechanisms and treatment of cancer cachexia. Nutrition, Metabolism and Cardiovascular Diseases 23:S19−S24

doi: 10.1016/j.numecd.2012.04.011
[22]

Meng Q, Tan S, Jiang Y, Han J, Xi Q, et al. 2021. Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: a randomized clinical trial. Clinical Nutrition 40:40−46

doi: 10.1016/j.clnu.2020.04.043
[23]

Ottery FD. 1996. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12:S15−S19

doi: 10.1016/0899-9007(95)00067-4
[24]

WeChat (Tencent Holdings Ltd.) 1998. www.wechat.com/en/ (Accessed 12 September, 2025)
[25]

DaYingJia (Beijing Zhongke Bangni International Technology Co. L.). 2020. www.dyhomedr.com/#/user/public (Accessed 12 September, 2025)
[26]

Yang X, Chattopadhyay K, Hubbard R, Li JL, Li L, Lin Y. 2021. 36-Month evaluation of a weight management programme in Chinese overweight and obese adults. Frontiers in Public Health 9:749302

doi: 10.3389/fpubh.2021.749302
[27]

Wen X, Wang M, Jiang CM, Zhang YM. 2011. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pacific Journal of Clinical Nutrition 20:551−556
[28]

Chinese Society of Nutritional Oncology. 2022. Guidelines for clinical diagnosis and treatment of cancer-related sarcopenia. Electronic Journal of Metabolism and Nutrition of Cancer 9:24−34
[29]

Hu B, Yang XR, Xu Y, Sun YF, Sun C, et al. 2014. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clinical Cancer Research 20:6212−6222

doi: 10.1158/1078-0432.CCR-14-0442
[30]

Onodera T, Goseki N, Kosaki G. 1984. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001−1005
[31]

Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, et al. 2021. ESPEN practical guideline: Clinical nutrition in surgery. Clinical Nutrition 40:4745−4761

doi: 10.1016/j.clnu.2021.03.031
[32]

Oh SE, Choi MG, Seo JM, An JY, Lee JH, et al. 2019. Prognostic significance of perioperative nutritional parameters in patients with gastric cancer. Clinical Nutrition 38:870−876

doi: 10.1016/j.clnu.2018.02.015
[33]

Chen X, Zhao G, Zhu L. 2021. Home enteral nutrition for postoperative elderly patients with esophageal cancer. Annals of Palliative Medicine 10:278−284

doi: 10.21037/apm-20-2197
[34]

Kim SH, Lee SM, Jeung HC, Lee IJ, Park JS, et al. 2019. The effect of nutrition intervention with oral nutritional supplements on pancreatic and bile duct cancer patients undergoing chemotherapy. Nutrients 11(5):1145

doi: 10.3390/nu11051145
[35]

Cornejo-Pareja I, Ramirez M, Camprubi-Robles M, Rueda R, Vegas-Aguilar IM, et al. 2021. Effect on an oral nutritional supplement with β-hydroxy-β-methylbutyrate and vitamin D on morphofunctional aspects, body composition, and phase angle in malnourished patients. Nutrients 13(12):4355

doi: 10.3390/nu13124355
[36]

Ferreira WA, Martucci RB, Souza NC. 2025. Impact of adherence to oral nutritional supplements on nutrition status and muscle strength in patients with gastrointestinal cancer: a prospective observational longitudinal study. Nutrition in Clinical Practice 40:420−430

doi: 10.1002/ncp.11239
[37]

Borges TC, Gomes TLN, Pimentel GD. 2020. Sarcopenia as a predictor of nutritional status and comorbidities in hospitalized patients with cancer: a cross-sectional study. Nutrition 73:110703

doi: 10.1016/j.nut.2019.110703
[38]

Franzoi MA, Agostinetto E, Perachino M, Del Mastro L, de Azambuja E, et al. 2021. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. The Lancet Oncology 22:e303−e313

doi: 10.1016/S1470-2045(20)30666-5
[39]

Gilliam LA, St Clair DK. 2011. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxidants & Redox Signaling 15:2543−2563

doi: 10.1089/ars.2011.3965
[40]

Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, et al. 2018. Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia. European Journal of Translational Myology 28:7590

doi: 10.4081/ejtm.2018.7590
[41]

Bozzetti F. 2020. Chemotherapy-Induced Sarcopenia. Current Treatment Options in Oncology 21:7

doi: 10.1007/s11864-019-0691-9
[42]

Argilés JM, Campos N, Lopez-Pedrosa JM, Rueda R, Rodriguez-Mañas L. 2016. Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. Journal of the American Medical Directors Association 17:789−796

doi: 10.1016/j.jamda.2016.04.019
[43]

Murphy RA, Wilke MS, Perrine M, Pawlowicz M, Mourtzakis M, et al. 2010. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clinical Nutrition 29:482−487

doi: 10.1016/j.clnu.2009.11.006
[44]

Park MJ, Choi KM. 2023. Interplay of skeletal muscle and adipose tissue: sarcopenic obesity. Metabolism 144:155577

doi: 10.1016/j.metabol.2023.155577
[45]

Don BR, Kaysen G. 2004. Serum albumin: relationship to inflammation and nutrition. Seminars in Dialysis 17:432−437

doi: 10.1111/j.0894-0959.2004.17603.x
[46]

Corrao G, Cantarutti A. 2018. Building reliable evidence from real-world data: Needs, methods, cautiousness and recommendations. Pulmonary Pharmacology & Therapeutics 53:61−67

doi: 10.1016/j.pupt.2018.09.009